Company Filing History:
Years Active: 2025
Title: Yiwei Shen: Innovator in Pharmaceutical Formulations
Introduction
Yiwei Shen is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on improving the efficacy and usability of medications.
Latest Patents
Yiwei Shen holds a patent for an oral solid tablet comprising Bruton's Tyrosine Kinase inhibitor. The patent describes an oral solid tablet that includes (S)-7-[4-(1-acryloylpiperidine)]-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide. This formulation exhibits excellent drug release characteristics, ensuring easy administration and quick, efficient release. The preparation method is straightforward, requiring no special equipment, which enhances formulation stability and facilitates transportation and storage. This innovation is particularly suitable for large-scale production.
Career Highlights
Yiwei Shen is associated with Beigene Switzerland GmbH, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on the pharmaceutical industry.
Collaborations
He collaborates with notable colleagues, including Gang Qiu and Wenyuan Fan, contributing to a dynamic research environment that fosters innovation.
Conclusion
Yiwei Shen's contributions to pharmaceutical formulations highlight his role as a key innovator in the industry. His patent for an oral solid tablet demonstrates his commitment to enhancing drug delivery systems. His work continues to pave the way for advancements in medication administration and production.